95 filings
Page 2 of 5
8-K
qt9tuspab9wc
6 Dec 23
Regulation FD Disclosure
5:00pm
8-K
squt1zo aeu
5 Dec 23
Regulation FD Disclosure
7:30am
8-K
87hjd8 dg
17 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
6tjlupwxfkem4xs
13 Nov 23
Regulation FD Disclosure
8:35am
8-K
mpqnfi9qpv8pqq7r rd
30 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
19yzyfer62 k64r4qlw2
27 Sep 23
Material Modifications to Rights of Security Holders
4:30pm
8-K
efr3 z9gmf
15 Sep 23
Entry into a Material Definitive Agreement
8:45am
8-K
yovs9 xm5sku
11 Aug 23
Departure of Directors or Certain Officers
8:15am
8-K
x3gznivid
27 Jul 23
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
4:01pm
8-K
cinip1r
17 Jul 23
Other Events
5:10pm
8-K
alh87bjqxn9j0o3p7
11 Jul 23
Entry into a Material Definitive Agreement
4:05pm
8-K
rqhbpnk
6 Jul 23
Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering
6:05am
8-K
9qh9gd
5 Jul 23
Other Events
4:31pm
8-K
f93s914
30 Jun 23
Entry into a Material Definitive Agreement
4:05pm
8-K
4bt3d5cz6 sty7nw
28 Jun 23
Allarity Therapeutics Announces Reverse Stock Split of
4:01pm
8-K
kebmxiajfyu s0cm
23 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
dfx5tfs
20 Jun 23
Allarity Therapeutics Announces Adjournment of Special Meeting of Stockholders
4:30pm
8-K
s7n2 cbcs
1 Jun 23
Entry into a Material Definitive Agreement
5:00pm
8-K
98m92mtgvlcl0ec
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
7hyrybtyaghv9024f2
2 May 23
Other Events
12:00am